A Short Practice of Clinical Cases

A Short Practice of Clinical Cases It is a page purposed for demonstrating and discussion about various clinical cases for doctors, medical students.

Name the MRI findings
30/12/2025

Name the MRI findings

30/12/2025

Name some indication of this procedure

30/12/2025
What's the findings in fundus??
22/12/2025

What's the findings in fundus??

Radiological findings
21/12/2025

Radiological findings

12/12/2025
12/12/2025
Put your differential diagnosis?
10/12/2025

Put your differential diagnosis?

ADA Standards of Care 2026: The New Algorithm for Glucose-Lowering Therapy in Type 2 DiabetesThe ADA 2026 reinforces a p...
10/12/2025

ADA Standards of Care 2026: The New Algorithm for Glucose-Lowering Therapy in Type 2 Diabetes

The ADA 2026 reinforces a priorities-first approach:
1️⃣ Reduce cardiovascular & kidney (CVKD) risk
2️⃣ Manage weight
3️⃣ Achieve glycemic goals
4️⃣ Address MASLD/MASH risk
All built on a foundation of healthy lifestyle + DSMES + addressing SDOH.

🔶 1. FIRST PRIORITY: Cardiovascular & Kidney Risk Reduction

A. ASCVD or Indicators of High CV Risk

Preferred: GLP-1 RA with proven CV benefit

Alternative / Add-on: SGLT2i with proven CV benefit

If HbA1c above target → combine GLP-1 RA + SGLT2i

B. Heart Failure (HFpEF or HFrEF)

Preferred: SGLT2 inhibitor

Add GLP-1 RA (proven benefit) if glycemia not controlled or if comorbid obesity

C. CKD (eGFR

The field of diabetes care is rapidly changing as new research, technology, and treatments that can improve the health and well-being of people with diabet

কি কি ফাইন্ডিং আছে? রেডিওলজিক্যালি কি ডায়াগনোসিস?
29/11/2025

কি কি ফাইন্ডিং আছে?
রেডিওলজিক্যালি কি ডায়াগনোসিস?

27/11/2025

Name of Scoring system?
For what condition you have to do?

Address

Dhaka

Telephone

+8801924243337

Website

Alerts

Be the first to know and let us send you an email when A Short Practice of Clinical Cases posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category